#

Rofecoxib, but not celecoxib, increases the risk of thromboembolic cardiovascular events in young adults : a nationwide registry-based study

Skoða fulla færslu

Titill: Rofecoxib, but not celecoxib, increases the risk of thromboembolic cardiovascular events in young adults : a nationwide registry-based studyRofecoxib, but not celecoxib, increases the risk of thromboembolic cardiovascular events in young adults : a nationwide registry-based study
Höfundur: Björn Guðbjörnsson 1955 ; Sigurður B. Þorsteinsson 1943 ; Helgi Sigvaldason 1931 ; Rannveig Alma Einarsdóttir 1953 ; Magnús Jóhannsson 1942 ; Helga Zoëga 1976 ; Matthías Eggert Halldórsson 1948 ; Guðmundur Þorgeirsson 1946
URI: http://hdl.handle.net/10802/16923
Útgáfa: 2010
Efnisorð: Lyfjafræði; Verkjalyf; Lyfjanotkun; Áhættuþættir; Hjartasjúkdómar; Æðasjúkdómar; Ungt fólk; Ísland
Tungumál: Enska
Tengd vefsíðuslóð: https://link.springer.com/content/pdf/10.1007/s00228-010-0789-2.pdf
Tegund: Tímaritsgrein
Gegnir ID: 991010916319706886
Birtist í: European journal of clinical pharmacology. 2010; 66 (6): bls. 619-625
Athugasemdir: Myndefni: Töflur.


Skrár

Skrá Stærð Skráartegund Skoða Lýsing
Gudbjornsson2010_Article_RofecoxibButNotCelecoxibIncrea.pdf 133.5Kb PDF Aðgangur lokaður Heildartexti

Þetta verk birtist í eftirfarandi flokki:

Skoða fulla færslu

Leita


Fletta